HP
PHVS icon

HealthInvest Partners’s Pharvaris PHVS Stock Holding History

HealthInvest Partners’s Portfolio PHVS Stock Details PHVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-34,328
Closed -$653K – 40
2024
Q4 		$653K Hold
34,328
– – 0.31% 35
2024
Q3 		$636K Hold
34,328
– – 0.3% 36
2024
Q2 		$645K Buy
+34,328
New +$699K 0.39% 35

Other funds holding PHVS

GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

HealthInvest Partners's PHVS Position: Q1 2025 in Review

HealthInvest Partners sold out of Pharvaris (PHVS) in Q1 2025, closing a stake of 34,328 shares — an estimated $653K sold.

HealthInvest Partners first reported a position in PHVS in Q2 2024 and held it in 3 quarters. The position peaked at $653K in Q4 2024. 52 funds tracked by Wall St. Rank hold PHVS as of Q1 2025.

  • HealthInvest Partners reported no remaining Pharvaris position as of Q1 2025 after selling out during the quarter.
  • HealthInvest Partners sold 34,328 Pharvaris shares in Q1 2025, an estimated $653K.
  • HealthInvest Partners first reported a position in Pharvaris in Q2 2024 and held it in 3 quarters.
  • HealthInvest Partners's Pharvaris position peaked at $653K in Q4 2024.
  • 52 funds tracked by Wall St. Rank held Pharvaris as of Q1 2025.

Based on HealthInvest Partners's 13F filing for Q1 2025, filed 5 May 2025.